Femasys Revenue and Competitors

Atlanta, Ga USA

Location

#8118

Growjo Ranking

Estimated Revenue & Valuation

  • Femasys's estimated annual revenue is currently $10M per year.(i)
  • Femasys received $4.0M in venture funding in January 2017.
  • Femasys's estimated revenue per employee is $200,800
  • Femasys's total funding is $69M.

Employee Data

  • Femasys has 50 Employees.(i)
  • Femasys grew their employee count by 4% last year.

Femasys's People

NameTitleEmail/Phone
1
SVP, Regulatory & Clinical AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M29N/AN/AN/A
#2
$104.7M4173%N/AN/A
#3
$6M24-23%N/AN/A
#4
$5M400%$16MN/A
#5
$6M24-23%N/AN/A
#6
$10.8M435%N/AN/A
#7
$3M240%$50MN/A
#8
$10M40-13%N/AN/A
#9
$5M2011%N/AN/A
#10
$17.6M703%N/AN/A
Add Company

What Is Femasys?

Our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. The pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. The team is complemented by world-class medical advisors. Our products have been organically conceived, researched and developed by the Company and all manufacturing activities are conducted to ensure compliance with the U.S. Food and Drug Administration (FDA) per the requirements of 21 CFR 820, as well as ISO 13485. Femasys has achieved significant milestones to date, including numerous issued patents and filings, recruitment of a team of experts, clearance of multiple regulatory filings by the U.S. Food and Drug Administration (FDA), European Union, Canada, and Japan with other select countries in process. Making a difference in the lives of women one product at a time is a great privilege and serves to drive the Company's mission.

keywords:Biotechnology,Finance,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$69M

Total Funding

50

Number of Employees

$10M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Femasys News

2022-04-13 - Short Interest in Femasys Inc. (NASDAQ:FEMY) Rises By 260.4%

Hedge funds have recently added to or reduced their stakes in the business. Millennium Management LLC bought a new stake in shares of Femasys in...

2022-03-22 - Femasys Inc. Announces Financial Results for the Year Ended ...

Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...

2022-03-22 - Femasys Inc. to Participate in the M-Vest 2022 Virtual Growth ...

Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...

2021-06-21 - FEMASYS INC. Chardan : Acts as Lead Left Bookrunner in Femasys' $34.45 Million IPO

NEW YORK, June 21, 2021 /PRNewswire/ -- Chardan, a global investment bank, today announced that it acted as lead left bookrunner in the successful closing of the $34.45 million IPO of Femasys, Inc. (NASDAQ: FEMY) a biomedical company focused on transforming women's healthcare by developing novel ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M506%$222.7M
#2
$13M500%N/A
#3
$6.5M50-7%$8.4M
#4
$6M50-12%N/A
#5
$4.8M500%N/A

Femasys Funding

DateAmountRoundLead InvestorsReference
2015-04-30$10.2MBLegacy Capital PartnersArticle
2016-08-16$3.3MUndisclosedArticle
2016-12-16$40.0MCSalem PartnersArticle
2017-01-19$4.0MUndisclosedSalem PartnersArticle